From 1991 to 1997, we have treated 78 newly diagnosed patients with aggressive non-Hodgkin's lymphoma with a modified CHOP regimen in which epirubicin (60 mg/m 2 ) was used in place of doxorubicin (50 mg/m 2 ), i.e. CEOP (cyclophosphamide, epirubicin, vincristine and prednisolone). The median age wa
β¦ LIBER β¦
The effect of optimal treatment on elderly patients with aggressive non-Hodgkin's lymphoma: more patients treated with unaffected response rates
β Scribed by F. Peters; M. Fickers; F. Erdkamp; J. Wals; J. Wils; H. Schouten
- Publisher
- Springer
- Year
- 2001
- Tongue
- English
- Weight
- 48 KB
- Volume
- 80
- Category
- Article
- ISSN
- 0939-5555
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
CEOP treatment results and validity of t
β
C. S. Chim; Y. L. Kwong; A. K. W. Lie; C. K. Lee; R. Liang
π
Article
π
1998
π
John Wiley and Sons
π
English
β 125 KB
π 2 views
Rituximab plus ASHAP for the treatment o
β
Semra Aydin; Ulrich DΓΌhrsen; Holger NΓΌckel
π
Article
π
2007
π
Springer
π
English
β 125 KB
A phase II trial of teniposide (VM 26) i
β
Dr. Umberto Tirelli; Antonino Carbone; Diana Crivellari; Rachele Volpe; Giovanni
π
Article
π
1984
π
John Wiley and Sons
π
English
β 418 KB
π 3 views
P139 Favourable therapeutic effect of ri
β
J.L. IvΓ‘nyi; Γ. Marton; M. Plander; G. GyΓ‘nΓ³; Cs. TΓ³th
π
Article
π
2007
π
Elsevier Science
π
English
β 58 KB
The effect of in vitro irradiation on mi
β
Samuel Rotstein; Edward Baral; Henric Blomgren; Bo Johansson
π
Article
π
1982
π
John Wiley and Sons
π
English
β 381 KB
π 2 views
Blood lymphocytes from 20 untreated patients with Hodgkin's disease were compared with those of 20 untreated patients with non-Hodgkin's lymphoma with regard to the responsiveness of the cells to PHA and ConA following exposure to varying doses of ionizing radiation in vitro. Lymphocytes from 19 of
Detection of soluble interleukin-2 recep
β
Roberto Stasi; Pier Luigi Zinzani; Piero Galieni; Vito Michele Lauta; Eugenio Da
π
Article
π
1994
π
John Wiley and Sons
π
English
β 875 KB